Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
View Scopus Profile
Tu Dan
Assistant Professor
,
Radiation Oncology
RO-Radiation Oncology
Email
tu.dan
utsouthwestern
edu
h-index
928
Citations
17
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2006
2025
Research activity per year
Overview
Fingerprint
Network
Research output
(53)
Similar Profiles
(7)
Fingerprint
Dive into the research topics where Tu Dan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Radiation Therapy
100%
Brain Metastasis
85%
Overall Survival
78%
Ganglioglioma
62%
Stereotactic Radiosurgery
56%
Neoplasm
47%
Surgery
46%
Disease
40%
Malignant Neoplasm
35%
Re-Irradiation
34%
Radiosurgery
33%
Hazard Ratio
32%
Cohort Analysis
26%
Breast Cancer
23%
Glioblastoma
22%
Brain Radiation
22%
Caloric Restriction
22%
Proton Therapy
22%
Pediatric Brain Tumor
22%
Bevacizumab
22%
Whole Body Radiation
22%
Metastatic Carcinoma
21%
Radiation Oncology
21%
Neuro-Oncology
20%
Triple Negative Breast Cancer
20%
Head and Neck Cancer
19%
Toxicity
18%
Recurrent Disease
16%
Intensity Modulated Radiation Therapy
16%
Radiation Exposure
16%
Linear Regression Analysis
16%
Radiation Response
15%
Whole Brain Radiotherapy
14%
Neck
13%
Systemic Therapy
13%
Positron Emission Tomography
13%
Lung Cancer
12%
Contralateral
12%
Computer Assisted Tomography
12%
Stereotactic Body Radiation Therapy
12%
Cyberknife
11%
microRNA 21
11%
Radioisotope
11%
Phase II Trials
11%
Tonsil Cancer
11%
Power Law
11%
Human Study
11%
Meningioma
11%
Breast-Conservation Therapy
11%
Hematopoietic Stem Cell
11%
Keyphrases
Overall Survival
60%
Radiation Therapy
48%
Stereotactic Radiosurgery
35%
High-grade Glioma
34%
Re-irradiation
34%
Brain Metastases
34%
Hazard Ratio
32%
Bevacizumab Treatment
22%
Genomic Techniques
22%
Response Predictors
22%
Response to Radiation
22%
Neuro-oncology
21%
Local Failure
20%
Radiation Exposure
17%
Risk Factors
17%
Total Body Irradiation
16%
Adverse Radiation Effect
15%
Clinical Practice
15%
Predictive Models
15%
Surgical Resection
15%
Glioblastoma
14%
Glioma
14%
Bevacizumab
14%
Poor Prognosis
14%
Radiosurgery
13%
Positron Emission Tomography
13%
MicroRNA
13%
Randomized Trial
13%
Single Fraction
13%
MicroRNA-21 (miR-21)
13%
Clinical Treatment
12%
Multivariable
12%
Multicenter Cohort Study
12%
Systemic Therapy
12%
Node-positive
12%
Nodal Failure
11%
Caloric Restriction
11%
Skin Model
11%
Clinical Experience
11%
Murine Skin
11%
Neoadjuvant
11%
Cell Viability
11%
Fractionated Stereotactic Radiotherapy
11%
Neutrophilia
11%
Toxic Effects
11%
Treatment Outcome
11%
Radioisotopes
11%
False Positive Reduction
11%
Prostate Cancer
11%
Volumetric Modulated Arc Therapy
11%
